While AI deals in Q3’24 included massive $1B+ rounds to defense tech provider Anduril and AI lab Safe Superintelligence, global AI funding actually dropped by 29% QoQ. This was driven by a 77% decline in funding from $1B+ AI rounds QoQ.

Based on our deep dive in the full report, here is the TL;DR on the state of AI:

• Global AI deal count climbs 24% QoQ to reach 1,245 — its highest quarterly level since peaking in Q1’22. This bucked the trend in overall venture deals (-10% QoQ), signaling that investor interest in AI remains strong despite the broader cooling in venture markets. AI funding, on the other hand, fell by 29% QoQ to $16.8B, driven by a 77% decline in funding from $1B+ AI rounds QoQ. 

• The average AI deal size is $23.5M in 2024 so far — up 28% vs. $18.4M in full-year 2023. This upward trend has been influenced by a rise in massive $1B+ deals, with AI startups drawing 9 of these deals in 2024 so far vs. 4 in full-year 2023. Top $1B+ rounds in 2024 YTD include: 
  • xAI — $6B Series B at a $24B valuation
  • Anthropic — $2.8B Series D at an $18.4B valuation
  • Anduril — $1.5B Series F at a $14B valuation
  • G42 — $1.5B investment from Microsoft
  • CoreWeave — $1.1B Series C at a $19B valuation

These deals aren’t solely responsible for pushing up the average — the median AI deal size is up 9% in 2024 so far.

• AI unicorn births more than double QoQ to reach 13 — 54% of the broader venture total in Q3’24. Generative AI continues to be a key theme for new unicorns (private companies reaching $1B+ valuations). More than half of the AI unicorns born in Q3’24 are genAI startups, and they are working across a variety of areas — including AI for 3D environments (World Labs), code generation (Codeium), and legal workflow automation (Harvey).

Among new genAI unicorns in Q3’24, Safe Superintelligence — co-founded by OpenAI co-founder Ilya Sutskever — landed the most sizable valuation. The AI lab was valued at $5B after raising a $1B Series A round in September 2024.

• AI M&A exits fall by 48% QoQ to hit 62 in Q3’24. The deals that did occur showcase how enterprises are strategically scooping up AI startups to improve their offerings and maintain a competitive edge. For example, the largest AI M&A deal in Q3’24 was AMD’s acquisition of AI lab Silo AI, which could help the semiconductor company enhance the development and deployment of AI models on its hardware. Meanwhile, Salesforce picked up unstructured data management startup Zoomin to support its AI agent offerings.

• Among major global regions, the US continues to lead in AI funding and deals. AI startups based in the US drew $11.4B across 566 deals in Q3’24, accounting for over two-thirds of global AI funding and 45% of global AI deals. Within the US, Silicon Valley still dominates AI funding and deals, but other metros are gaining ground. In Q3’24, Los Angeles and New York saw their AI deal counts rise QoQ while Silicon Valley watched its count drop for the second quarter straight.

ADDITIONAL AI RESEARCH FROM CB INSIGHTS:

• State of AI Q2’24 Report
• State of Venture Q3’24 Report
• Game Changers 2025: 9 technologies that will change the world
• The Multi-Agent AI Outlook: Here’s what you need to know about the next major development in genAI
• Analyzing a16z’s AI investment strategy: Where the firm sees opportunity amid the genAI rush
• The AI computing hardware market map

The post State of AI Q3’24 Report appeared first on CB Insights Research.

Meanwhile, M&A activity is on the rise, climbing for the second straight quarter in Q3’24.

Based on our deep dive in the full report, here is the TL;DR on the state of digital health:

• Global digital health funding drops 23% QoQ to hit $3.3B in Q3’24, marking the second-lowest quarterly funding level since 2017. This decline comes despite a slight uptick in deal count QoQ. However, the average deal size in 2024 YTD is $17.8M — a 51% increase from the full-year 2023 average of $11.8M. This jump in average deal size, amid a downturn in deals over the same period, reflects that investors are concentrating larger sums on fewer, later-stage ventures.

• Digital health mega-round deals ($100M+ deals) drop slightly in Q3’24, falling from 9 to 7 QoQ. Meanwhile, mega-round funding and share of total funding also declined QoQ, underscoring a more cautious investor approach. Mega-rounds accounted for 30% of total digital health funding in Q3 — down from 44% in Q2. Top Q3’24 mega-rounds (by round amount) included:
  • Women’s health app Flo Health‘s $200M Series C
  • Digital-first health insurance provider Alan‘s $193M Series F

• The US accounts for 52% of digital health deals in Q3’24, down from 61% in Q2. Meanwhile, Europe and Asia both saw their deal shares rise to 21% in Q3. Asia experienced a greater jump in deal share, gaining 7 percentage points QoQ while Europe gained 3. This shift suggests growing investor interest in markets outside of traditional US hubs.

• Q3’24 sees the emergence of 2 new digital health unicorns — both based in Europe. The newest members of the digital health unicorn club are UK-based Flo Health, a women’s health app, and Huma, a remote patient monitoring platform. Against the backdrop of a broader downturn in new digital health unicorns, these births highlight Europe’s growing importance in the digital health landscape.

• Digital health M&A exits continue to climb in Q3’24, rising 23% QoQ to 37. This rising M&A appetite may be partly fueled by established companies seizing opportunities to scoop up innovative technologies amid a challenging funding environment for startups. The largest M&A deal in Q3’24 was LetsGetChecked’s $525M acquisition of digital pharmacy Truepill.

MORE DIGITAL HEALTH RESEARCH FROM CB INSIGHTS

• State of Digital Health Q2’24 Report
• Digital Health M&A: Every second acquisition in 2024 has been an AI company
• The $4.6B opportunity in healthcare: Ambient AI to target clinician burnout
• Analyzing Eli Lilly’s growth strategy: How the pharma giant is leveraging AI and pioneering a direct-to-patient approach
• Prioritizing clinical trials tech: How 16 tech-driven markets stack up across maturity and momentum

The post State of Digital Health Q3’24 Report appeared first on CB Insights Research.

However, average deal size has remained roughly stable in 2024 YTD, suggesting dealmakers are putting more money behind a select group of fintech companies.

Download the full report to access comprehensive data and charts on the evolving state of fintech across sectors, geographies, and more.

Below, we cover key takeaways from the report.

• Global fintech funding sinks to $7.3B, a 25% QoQ decline. However, Q2’24 funding was propped up in part by mega-rounds for Stripe and AlphaSense totaling $1.3B. Excluding those rounds, the decline from Q2’24 to Q3’24 would have been 13%.

• Deal volume drops 16%. Total deals for fintechs continued to decline, falling 16% from 892 in Q2’24 to 753 in Q3’24. This marks the lowest quarterly level since 2017. For comparison, fintech deal volume clocked in at nearly 1,500 two years ago, in Q3’22 — roughly double where it stands now.

• Average deal size remains stable at $12.7M. Despite deal volume declining, average deal size has remained roughly flat YTD, at $12.7M, compared to $13.2M for full-year 2023. The decline in deal volume and stable deal size indicates dealmakers narrowed their focus to fewer, higher-dollar bets.

• 52% of the top early-stage deals are in less-crowded fintech markets. Just over half of the top early-stage deals occurred in financial services markets outside the US and UK — in countries like France, India, Italy, and Kenya. Less-crowded markets like these offer more room for early-stage fintechs to find niches and grow their client bases. 

• Wealth tech funding increases by 67%, thanks to 2 $100M+ mega-rounds. Wealth tech funding increased the most of any fintech sector QoQ, from $0.6B in Q2’24 to $1.0B in Q3’24. The increase was fueled by 2 substantial deals: 
  • $242M Series F round for turnkey retirement plan provider Human Interest. 
  • $200M Series B round for Earned Wealth, a digital wealth manager targeting medical professionals.
    

ADDITIONAL FINANCIAL SERVICES RESEARCH FROM CB INSIGHTS:

• State of Venture Q3’24 Report
• The embedded finance market ranking: Where integrated financial services are maturing, emerging, and plateauing
• The financial planning market map
• State of Fintech Q2’24 Report

The post State of Fintech Q3’24 Report appeared first on CB Insights Research.

In some ways venture has become less dramatic. The period of steep decline in funding that followed the dizzying heights of 2021 has given way to relatively moderate quarterly variations.

But even in a more sober fundraising environment, excitement over AI has become a major driving force for investors. One in every 3 VC dollars now goes to the tech. Silicon Valley, a major AI hub, is tightening its hold on investor cash. AI startups are exiting years faster than those working on other technologies.

As interest rates fall and the appetite for riskier assets increases, expect AI startups to be top of mind for an increasing number of investors in the months ahead.

Download the full report to access comprehensive data and charts on the evolving state of VC across sectors, geographies, and more.

Below, we cover key shifts in the landscape, including:

1. Quarterly declines in global VC funding and deals
2. AI startups grab 1 in 3 VC dollars
3. Performance from recent tech IPOs
4. Silicon Valley is only getting stronger
5. New unicorns remain rare
6. The US claims the bulk of AI innovation
7. How global VC stacks up against economic output
8. 76% of top deals go to B2B startups
9. AI startups exit 6 years sooner than the rest of tech

Let’s dive in.

Topline figures paint a sobering picture for venture, as both global funding and deals ticked down quarter-over-quarter (QoQ). The quarterly levels place Q3’24 on par with where VC was in 2016/2017.

However, while deal volume has progressively declined, the size of deals that do happen has grown. In 2024 so far, the average deal clocks in at $13.9M (up from $12M in full-year 2023), while the median is worth $3M (up from 2023’s $2.5M). 

The more cautious investment environment is likely driving a flight to quality as selective investors isolate the most promising ventures.

AI startups are capturing nearly a third (31%) of all venture funding right now — the second-highest share on record, following Q2’s 35%.

Within AI, a company’s age and stage don’t always correlate to the size of financing rounds. One of the largest rounds in Q3’24, for instance, was a mammoth $1B deal to Safe Superintelligence (SSI) — an early-stage startup founded in June by OpenAI co-founder Ilya Sutskever. The company has just 10 employees.

SSI’s deal is the 9th $1B+ AI equity round this year. Given their willingness to participate in such large rounds to so many companies, investors appear confident that a new tech giant will emerge from the space — and apparently have FOMO.

Yet despite investors’ bullishness, many of today’s fledgling AI startups will struggle to live up to lofty expectations, and some will ultimately fail. Even AI giants like OpenAI face the daunting task of keeping costs in control: the AI leader’s losses are expected to amount to $5B this year. 

The AI boom is also giving recent public debuts a boost. 

We analyzed 15 of the companies with the largest tech IPOs since 2022 to see whether they’ve gained or lost value since they filed to go public IPOs. The majority (10 out of 15) have either held steady or gained value as public players — a positive indicator for tech IPOs more broadly, which until recently were getting beaten down badly in the public markets. The fact that startups are able to maintain and even gain value as public companies will likely draw out other IPO-ready companies.

And AI is an important factor driving gains for several of these companies. For instance:

• Arm’s value has nearly tripled since it debuted late last year. The chip designer is a leader in CPUs for AI computing hardware, including providing the architecture for AI chip firms like Nvidia.
• Tempus is deploying AI across its precision medicine offerings, which has helped buoy its value by 31% since its IPO filing. (It legally changed its name from Tempus Labs to Tempus AI in early 2023.)
• Like Arm, Astera Labs, which offers AI infrastructure & connectivity hardware, has benefited from the swell in widespread adoption of AI. Its value has grown 45% since filing in March 2024. 

It’s not universal — enterprise AI firm 4Paradigm, for instance, has seen its value slashed by over half since debuting. But this could be due more to geopolitical forces, as China-based 4Paradigm has faced an uphill battle in sustaining investor interest because of US restrictions. (4Paradigm was placed on a US export control list in early 2023.) 

Customers: explore data behind these 15 IPOs

Another result of the AI explosion: Cash is concentrating in Silicon Valley, home to over a third of the US-based AI startups. In fact, the metro’s share of US venture funding — across sectors — has climbed to a recent high of 41% this year.

In Q3’24, Silicon Valley-based startups raised $10.5B — more than 2.5x that of New York ($3.9B), the second-ranked metro. LA and Boston follow, with $2.9B and $2.8B, respectively. 

Notably, deal activity in Silicon Valley remains overwhelmingly early-stage — meaning it’s not just a handful of more established startups raising massive rounds. More than two-thirds of Silicon Valley’s deals this year are at the seed or Series A stages.

See every AI company in Silicon Valley

Newly minted billion-dollar startups remain few and far between. Q3’24 saw 24 startups reach that mark — a noticeable bump from the previous quarter’s 16, though a fraction of what we saw during the tech boom of 2021 and early 2022. 

Valuations remain pressured at the later stages of investment, with many of the unicorns minted in years gone by likely worth less than $1B in reality. On the other hand, valuations are showing strength at the earlier stages. Among seed-stage startups, the median valuation for deals this year is $13.5M — the highest annual level on record.

There are a few common themes among the latest batch of new unicorns:

• AI is minting more unicorns than any other sector. More than half of the new unicorns in Q3’24 are AI companies. Among these, several are working to bring greater spatial awareness to AI systems, from Skild AI’s intelligent humanoid robotics to World Labs’ 3D world-building tools. Others are developing enterprise AI agents & copilots, like Harvey in the legal domain and Codeium in software engineering.
• India’s startups are climbing the ranks. The country contributed 3 of Q3’24’s new unicorns: Ather Energy, MoneyView, and Rapido. India ranks third globally for total unicorns after the US and China, and it had a strong funding quarter in Q3’24, with startups raising $4B — up 29% QoQ and 111% YoY.
• a16z and Sequoia are the most active investors in backing new unicorns. The investors each backed 4 of Q3’24’s freshly minted $1B+ companies. Andreessen Horowitz invested in Saronic Technologies, World Labs, Story Protocol, and Safe Superintelligence; while Sequoia Capital backed Skild AI, Harvey, Chainguard, and Safe Superintelligence.

See the 24 new unicorns with this search

CB Insights tracks over 15,000 AI startups globally. And while 99 countries and regions around the world have at least 1 AI startup, the US is the undisputed leader in AI startup activity — and by a substantial margin. 

43% of all AI startups are based in the country. The distant No. 2 and No. 3 countries are China (9% of AI startups) and the UK (7%). 

View 15,000+ AI startups in the Expert Collection

While the US has long dominated the global venture scene when it comes to absolute funding and deal activity, several countries rank above the US in terms of the ratio of venture funding to GDP: the United Arab Emirates, Israel, and Singapore. 

These 3 countries pace ahead of the US in terms of VC as a proportion of overall economic activity, suggesting they are punching above their weight in terms of fostering startup activity. 

For instance, UAE-based startups have raised over $3B in funding over the last year (since 10/1/2023), and the country’s 2023 GDP came in at $504B. That represents $1 in VC to $158 in GDP (1/158) — a stronger ratio than any other country with at least $1B in annual venture funding.

Activity in the region has recently been fueled by AI firm G42, which raised a $1.5B round from Microsoft in April. (As part of the deal, G42 will use Microsoft’s Azure cloud offering, and Microsoft will also gain access to G42’s data centers.)

Israel and Singapore hold the No. 2 and 3 spots, with venture funding to GDP ratios of 1/166 and 1/198, respectively. 

Explore top Q3 venture deals for the UAE, Israel, & Singapore

Right now, the venture capital industry is all in on B2B startups. Among the 100 largest deals in Q3’24, three-fourths went to startups that use a B2B business model (either exclusively or in combination with other models like B2C or B2G). 

The B2B distribution model — particularly at the enterprise level — has gained appeal in recent years as a potentially more stable, recurring source of revenue for startups, especially during periods of volatile consumer spending.

See the top B2B venture deals in Q3’24

The buzz around AI is translating to faster exit velocity for startups in the space. Breaking down all the exits that have taken place this year, it’s clear AI startups exit at a much faster rate — 6 years faster, to be exact. It takes the median AI company just 7 years to exit from the year it was founded, compared to 13 years for non-AI companies.

While this trend holds true for recent AI IPOs, it’s most commonly seen among M&A deals, which represent the vast majority of AI exits this year.

Corporations are among the top acquirers of AI startups, with many looking to gain an edge by rapidly adding novel AI tools to their product suites.

• Nvidia has acquired 3 AI startups this year: Deci and Run:ai, both in April; and OctoAI, just last week. All 3 operate at the infrastructure layer of AI development and signal Nvidia’s ambitions to expand across the AI software stack.
• Zendesk has acquired 2 customer service-focused players — Ultimate and Klaus — as it builds out its own AI agent offering to automate customer interactions.
• Salesforce has similarly pledged to go all in on AI agents. To this end, it acquired 2 AI startups last month: Tenyx and Zoomin.

Another driving factor is “acqui-hires,” where an acquirer purchases a startup primarily for its talent. We’ve seen this among some of the youngest AI startups to be acquired. For instance, SydeLabs and Laiyer, both founded in 2023, were acquired by Protect AI this year. In both cases, Protect AI absorbed the startups’ teams.

See the AI startups most likely to get acquired next

The post State of Venture Q3’24 Report appeared first on CB Insights Research.

Amid the funding decline, investors are favoring smaller mid- and late-stage deals. However, they are still willing to place early-stage bets where they see strong opportunities.

Based on our deep dive in the full report, here is the TL;DR on the state of climate tech:

• • Global climate tech funding declines by 20% QoQ to $4.9B in Q2’24 — the lowest quarterly total since Q2’20. While deal count rebounded QoQ to 397 in Q2, it still came in well below 2023’s quarterly totals.

• • Climate tech doesn’t see any unicorn births (private companies reaching $1B+ valuations) in Q2’24, marking climate tech’s second straight quarter without any new unicorns. This coincides with a decline in late-stage deal sizes — the median deal size at that stage is $38M in 2024 YTD, down 16% vs. full-year 2023.

• • Late-stage deal sizes decline, while early-stage sizes show strength. The median late-stage deal size is $38M in 2024 YTD — down 16% from full-year 2023. In contrast, median early-stage size is up 39% YTD, suggesting that investors are still willing to place bets where they see strong early-stage opportunities. Two of the largest early-stage deals in Q2’24 went to Cylib and Aether Fuels. Both companies intend to use the funding to scale and support commercialization initiatives — goals that are generally communicated by later-stage companies.

• • $100M+ mega-rounds continue to trend down in Q2’24. Climate tech mega-rounds dropped from 17 in Q1’24 to 9 in Q2’24. The majority of Q2’24’s mega-round recipients are focused on scaling operations and achieving full-scale commercialization. For example, one of the quarter’s largest deals ($375M Series G) went to battery materials developer Sila, which plans to use the funding to ramp up silicon anode production.

Source: CB Insights — Sila Funding Insights

• Climate tech funding drops yet again in Asia. Climate tech startups in the region raised a total of $0.4B in Q2’24, down 33% QoQ and 89% YoY. China suffered the sharpest funding decline (-90% QoQ) among highlighted countries in the region. India and Japan watched funding fall by 28% and 57% QoQ, respectively.

More energy resources from CB insights

• 5 climate tech markets gaining momentum in 2024
• The grid tech market map: The companies tackling the growing need for reliable electricity
• The energy impact of generative AI: 3 technologies transforming the future of data centers
• Analyzing 15 oil & gas leaders’ tech priorities: Here’s where incumbents are buying, investing, and partnering
• Sodium-ion batteries are poised for a breakout moment — energy players should prepare
• Why energy giants should have green ammonia on their radar

The post State of Climate Tech Q2’24 Report appeared first on CB Insights Research.

We provide a deep dive on the state of insurtech in the full report. Here’s the TL;DR:

• Global insurtech funding increases to $1.3B in Q2’24 — the highest level since Q1’23. Insurtech funding grew 44% QoQ — led by 50% growth in funding to P&C insurtechs, from $0.6B to $0.9B. Funding to life & health (L&H) insurtechs also increased QoQ, ticking up from $0.3B to $0.4B.

• Insurtech deal count falls 27% QoQ to 82, the lowest level since 2016. The drop was nearly proportional across P&C and L&H: P&C deals fell 28% to 54 deals, while L&H deals decreased by 26% to 28 deals. On a percentage basis, the decline in insurtech deals outpaced the broader venture and fintech environments (where deal activity fell 7% and 16% QoQ, respectively).

• Median insurtech deal size increases 25% from $4M in 2023 to $5M in 2024 YTD. Only 2021 has seen a higher median deal size over the past 10 years. However, while the median early-stage insurtech deal size is at a record-high $4M this year, late-stage deal size ($31M) is the lowest it’s been since 2018. Insurtech mega-rounds (deals worth $100M+) were nearly nonexistent in Q2, with Sidecar Health, a health insurer, raising the quarter’s only such deal (a $165M Series D).

• Insurtech sees its first IPOs since Q3’22. Two insurtechs IPO’d in Q2’24 — Digit Insurance, an India-based insurance provider, and Saudi Arabia-based Rasan, which primarily focuses on auto insurance sales and vehicle services. Both IPOs occurred amid a broader lull in global IPO activity.

• Europe’s share of insurtech deals reaches 35% — a record high. Deals to Europe-based insurtechs stayed roughly steady, ticking up from 28 in Q1’24 to 29 in Q2’24. Comparatively, the US saw insurtech deal count fall from 61 to 40. Funding to Europe-based insurtechs reached a 7-quarter high ($0.5B), driven by two $93M deals for Finland-based ICEYE — a provider of data from satellite imagery — and UK-based Vitesse, a claims payments processor.

The post State of Insurtech Q2’24 Report appeared first on CB Insights Research.

Massive rounds to AI companies were a key driver of the funding growth, with 3 of the 5 largest CVC-backed deals this quarter going to AI infrastructure players Scale ($1B), Mistral AI ($502M), and Cohere ($450M).

Based on our 124-page report, here is the TL;DR on the state of CVC:

• ​​Global CVC-backed funding climbs to $15.6B in Q2’24. Over half ($8.4B) of this funding came from $100M+ mega-rounds. Meanwhile, global deal volume declined by 12% QoQ to 782. This drop was particularly pronounced in Asia, which saw a 24% drop in deals QoQ.
• This year, the average CVC-backed deal size is $26.6M, up 27% from $20.9M in full-year 2023. The increase is due in part to billion-dollar deals to startups like Scale ($1B Series F, backed by the CVC arms of Intel, AMD, Cisco, and ServiceNow) and Wiz ($1B Series E, backed by Salesforce Ventures).
• CVC-backed funding to digital health startups falls 57% QoQ to 0.6B, its lowest point since Q4’17. Retail tech and fintech saw similar decreases, with funding down 52% and 8% QoQ, respectively. Companies not explicitly focused on AI face challenges raising funds in the weakened venture market.

• Quarterly CVC-backed funding in China slips to $0.2B, a 60% QoQ decrease. Deal volume also fell 24% QoQ to 59, its lowest level since 2015. China’s tech market has faced significant challenges, including rising macroeconomic concerns, escalating geopolitical tensions, and a strict regulatory environment.

The post State of CVC Q2’24 Report appeared first on CB Insights Research.

Meanwhile, overall AI deal volume broke its extended freefall in Q2’24, rising by 16% QoQ to reach 948. This bucked the trend in venture deals more broadly (-7% QoQ).

Based on our deep dive in the full report, here is the TL;DR on the state of AI:

• Global AI funding increases 59% QoQ to $23.2B in Q2’24 — the highest quarterly level on record, exceeding even the level seen during 2021’s venture boom. The jump was driven by a handful of $1B+ rounds and outpaced the growth in broader venture funding (+8%). Meanwhile, AI deal count climbed by 16% QoQ to reach 948, bucking the trend in venture deals more broadly (-7% QoQ).

• Average AI deal size is $28.9M in 2024 so far — up 55% vs. $18.6M in full-year 2023. A relatively small number of players have had an outsized impact on this upward trend, raising massive $1B+ deals in Q2’24: 
  • xAI — $6B Series B at a $24B valuation
  • G42 — $1.5B investment from Microsoft 
  • CoreWeave — $1.1B Series C at a $19B valuation
  • Wayve — $1.05B Series C from Softbank, Microsoft, and Nvidia
  • Scale — $1B Series F at a $13.8B valuation

Meanwhile, the median AI deal size is up 25% in 2024 so far.

• AI unicorn births remain steady at 6 QoQ in Q2’24. Generative AI was a key theme for new unicorns (private companies reaching $1B+ valuations). Some of these companies, like xAI, are focused on generative AI infrastructure. Others are primarily working on generative AI applications, like Perplexity (search) and Cognition (coding).

Among new AI unicorns in Q2’24, xAI landed the most sizable valuation. The company was valued at $24B after raising $6B in Series B funding, which it plans to use to bring its first products to market.

• AI companies raise 32 mega-rounds (deals worth $100M+) in Q2’24, marking a 28% increase QoQ. Meanwhile, funding from AI mega-round deals climbed 74% QoQ in Q2’24. This was largely driven by US mega-round deals, which collectively amounted to $10.8B — 67% of AI mega-round funding in Q2.
• Among major global regions, the US continues to lead in AI funding and deals. AI startups based in the US drew $15.2B across 476 deals in Q2’24. This equates to 66% of the global AI funding total and 50% of the global deal total in Q2.

The post State of AI Q2’24 Report appeared first on CB Insights Research.

Amid the decline, investors have shifted their focus to writing fewer, larger checks for more mature companies in the digital health ecosystem. Meanwhile, their interest in early-stage companies has cooled.

Based on our deep dive in the full report, here is the TL;DR on the state of digital health:

• Global digital health funding declines by 26% QoQ, with funding falling to $2.9B across 235 deals in Q2’24 — the lowest quarterly deal volume seen since 2014. However, the annual average deal size globally is $16.7M in 2024 YTD, up 40% from the average for full-year 2023, signaling that investors are writing fewer but larger checks.

• US deal share grows to 61%, up from 54% in Q1’24. While digital health funding in the US declined by 18% QoQ in Q2’24, the US’ proportion of the global deal volume grew, marked by an increase in mid- to late-stage deal share. Median deal size is also up in the US in 2024 so far — sitting at $7.5M vs. $4.6M in full-year 2023.

• Mid-stage deal share jumps to 26% in 2024 YTD, while early-stage deal share falls by 14 percentage points. Early-stage deals have consistently accounted for 60%+ of all digital health deals in recent years. However, in 2024 YTD, early-stage deal share has dropped to 51% as mid- and late-stage deals have captured more investor interest. In the US, early-stage deal share has fallen to 45% in 2024 YTD vs. 62% in full-year 2023.

• $100M+ mega-rounds drop off in Q2’24 but are more varied across the digital health landscape. Digital health mega-rounds dropped from 8 in Q1’24 to 5 in Q2’24. While mega-rounds were focused on biotech in Q1’24, they were more spread out in Q2’24, spanning areas like care navigation, ultrasound tech, and value-based care tools. The largest deal of the quarter ($200M Series D) went to Foodsmart — a telenutrition company focused on chronic disease management.

Source: CB Insights — Foodsmart Funding Insights

• Digital health exits increase in Q2’24, rising from 26 to 32 QoQ. AI-driven platforms were the highlight here, with Tempus (precision medicine) and XtalPi (drug R&D) going public via IPO and Nuvo Group (remote pregnancy monitoring) going public via SPAC. Digital health M&A exit activity also picked up in Q2’24, especially in Europe, which saw M&A deals jump from 5 to 10 QoQ. Globally, virtual care, provider workflow tools, and drug R&D platforms were key categories for M&A in Q2’24.

The post State of Digital Health Q2’24 Report appeared first on CB Insights Research.

However, two huge deals — for market intelligence firm AlphaSense and payments juggernaut Stripe — obscured the reality that it was another tepid quarter for the sector as a whole.

Based on our deep dive in the full report, here is the TL;DR on the state of fintech:

• Funding increases by 19% quarter-over-quarter (QoQ), buoyed by 2 blockbuster deals. Quarterly funding rose in Q2’24 to $8.9B. But if it weren’t for 2 late-stage deals for Stripe ($694M) and AlphaSense ($650M), funding would have remained flat QoQ. A 16% decline in deal volume also indicates fintech investors remain cautious.​
• Average deal size decreases to $12.8M, down 4% vs. 2023. The slight decline in average deal size YTD highlights broad stagnation in fintech deal sizes. Yet, when looking at the median, deal size has ticked up from $3.1M in 2023 to $4M this year. The 29% increase could signal strength in the long tail of smaller fintech deals.
• Mid- and late-stage deal share is at 20% YTD, up from 18% in 2023. In a more favorable operating environment, investors are showing greater confidence in later-stage companies than they did in the past 2 years — especially in areas like payments and lending. In payments, mid- and late-stage rounds make up 27% of deals YTD, vs. 21% in 2023. In digital lending, mid- and late-stage deals make up 35% of deals YTD, compared to 20% in 2023. 
• 30% of the biggest early-stage deals are for digital asset companies. Crypto and blockchain-focused fintechs are receiving renewed focus, as the crypto winter thaws. Digital asset companies accounted for nearly one-third of the top 10 seed/angel and top 10 Series A rounds. The two largest early-stage deals in the crypto space went to digital asset infrastructure platforms TradeDog ($75M seed) and Biton ($44M Series A).
• US-based funding increases by 45% QoQ to $4.8B. In addition to the funding increase, the US led the world across a few metrics in Q2’24, including share of equity deals (40%) and exits (36%). Mega-rounds led the way: Nine of the 10 biggest deals in the US were worth $100M or more, the most since Q2’22. LatAm was the only other major global region with a funding increase, up by 22% to $442M.

The post State of Fintech Q2’24 Report appeared first on CB Insights Research.

Based on our deep dive below, here is the TL;DR on the state of venture:

1. Venture funding climbs for a second straight quarter, reaching $65.7B, up 8% quarter-over-quarter (QoQ). However, while funding gained momentum, deals slid for the ninth quarter in a row to 6,230. Global deal volume is now less than half of what it was at its peak in Q1’22.
2. At $14.4M, the average deal size is up 17% this year so far vs. 2023. Even in a more cautious investing environment, the deals that do happen have ballooned in size as investors put more behind select startups. 
3. AI startups are dominating global funding, capturing 35% in Q2’24. This is the highest quarterly share on record. AI startups drew $23.2B in Q2’24 — up 59% QoQ — driven by mammoth $1B+ deals to Elon Musk’s xAI as well as Scale, CoreWeave, and others. 
4. The US is attracting a greater portion of exit activity, with exit share rising 4 percentage points QoQ to 39%. This represents its highest share in 2 years. Top US-based exits in Q2’24 included IPOs from Tempus and Rubrik — both valued at over $5B — as well as Hyundai’s acquisition of Motional priced at $4.1B.
5. SOSV is the most active venture investor, backing 35 companies in Q2’24. It’s followed by Andreessen Horowitz (33 companies), General Catalyst (31 companies), and Lightspeed Venture Partners (28).
6. Fintech funding rebounds 19% QoQ to hit $8.9B — a 5-quarter high — led by $600M+ rounds to Stripe and AlphaSense. But it was a different story for the retail tech and digital health sectors: retail tech funding was stagnant from Q1 to Q2, while digital health funding slipped by 26%.
7. Quarterly funding to startups in Asia falls below $10B for the first time since 2014. The drop was especially severe in China, where some international investors have pulled back or retreated altogether amid rising geopolitical tensions. Meanwhile, the US and Europe — the two largest regions for venture investment — each saw funding grow by double-digit percentages in Q2’24.

Venture funding ticked up for a second consecutive quarter, reaching $65.7B in Q2’24. Nearly half of this funding (47%) came from mega-rounds (deals worth $100M+). xAI’s $6B round alone represented nearly one-tenth of the global total and helped prevent funding from declining QoQ.

Despite the strong showing, deal volume slipped for a ninth straight quarter — sinking 7% to 6,230 — as investors remain cautious in the less exuberant market. The US, Europe, and Asia all saw deal count decrease QoQ, while it grew slightly across Canada, LatAm, Africa, and Oceania.

With deals down and funding up, the average deal size has climbed this year, pacing at $14.4M — up 17% compared to full-year 2023. Notably, it’s not just a few massive deals that are pulling that figure up: the median deal size has also grown from $2.5M to $3M over the same period. 

Among investment stages, the median deal size has increased across early- and mid-stage rounds, while it has fallen slightly at the late stage.

One factor more than any other is driving gains in the venture market right now, and that’s AI. Startups developing AI solutions raised $23.2B in Q2’24 — accounting for 35% of the global total, the highest share ever recorded. This share has been trending up for several years now, especially since the arrival of OpenAI’s ChatGPT in late 2022.

Leading the pack among AI startups, Elon Musk’s xAI outfit raised a whopping $6B round in Q2’24. The 1-year-old company, now valued at $24B, had no trouble finding investors, who believe xAI will gain a competitive edge through integration with Musk’s network of companies (and their data). For instance, Tesla could use xAI’s latest multimodal AI model, which includes vision capabilities, to bring more advanced perception to its Optimus humanoid.

The Funding Insights from xAI’s CB Insights profile point to synergies between xAI and Musk’s other companies, like Tesla.

Other top AI rounds in Q2’24 went to:

• G42 — $1.5B investment from Microsoft
• CoreWeave — $1.1B Series C at a $19B valuation
• Wayve — $1.05B Series C from SoftBank, Nvidia, and Microsoft
• Scale — $1B Series F led by Accel, with backing from corporates including AMD, Amazon, Intel, and Nvidia

Customers can explore thousands of AI startups across industries and technologies in the CB Insights AI Expert Collection.

In Q2’24, the US saw 39% of all exits, which included both IPOs and M&A transactions. The figure represents an increase of 4 percentage points QoQ and puts the US in the No. 1 spot globally, tied with Europe.

Notably, US IPOs are gaining some strength, with Q2 seeing blockbuster debuts from Tempus (valued at $6.1B) and Rubrik ($5.6B). We predicted both companies would go public in our Tech IPO Pipeline report, published in late 2023. 

Go deeper with CB Insights buyer interviews for Tempus and Rubrik to see what their customers are saying.

Meanwhile, the US venture market’s top M&A deal went to Motional, an autonomous driving startup founded as a joint venture between Hyundai and Aptiv. Hyundai took a majority stake in the company at a $4.1B valuation. Per the Funding Insights on Motional’s CB Insights profile, Hyundai and Motional are co-developing a robotaxi service with a target release of 2024.

The Acquisition Insights from Hyundai’s CB Insights profile break down the structure and goals of the Motional deal.

Around the world, the most active venture investor right now is SOSV. The firm, which primarily backs early-stage startups, invested in 35 unique companies in Q2’24, placing it ahead of a16z (33 companies), General Catalyst (31), and Lightspeed (28). 

Customers can use this CB Insights platform search to see SOSV’s top portfolio companies ranked by Mosaic score — which measures a private company’s health — alongside data cuts like commercial maturity, headcount growth, and more.

Among industry sectors, fintech saw funding grow the most, watching it rise 19% QoQ to reach $8.9B. This marks a rebound for the sector vs. Q1’24. Top fintech deals in the quarter went to payments leader Stripe and market intelligence firm AlphaSense. 

The retail tech and digital health sectors were worse off than fintech. Retail tech funding was roughly stagnant QoQ, while digital health funding plummeted to below $3B — its second-lowest quarterly level since 2016.

Among major global regions, the US and Europe outpaced the market as a whole for funding growth in Q2’24. 

Asia, on the other hand, saw its funding fall 13% QoQ to $9.7B. The decline was most pronounced in China, where dollars tumbled more than 50% to $2.2B, whereas India, Singapore, and Japan all experienced funding growth QoQ. 

The top two equity deals in the region went to United Arab Emirates’ G42 and India-based Zepto.

The post State of Venture Q2’24 Report appeared first on CB Insights Research.

Driving this growth were mega-rounds (deals worth $100M+), which accounted for 47% of the funding — their highest share since Q1’22.

CVC deal count remained steady QoQ, again showcasing CVCs’ resilience compared to the broader venture market, which saw quarterly deals plummet to their lowest level in years.

Based on our 122-page report, here is the TL;DR on the state of CVC:

• ​Global CVC-backed funding rebounded 26% QoQ to reach $15B in Q1’24. Nearly half ($7B) of this funding came from $100M+ mega-rounds. Meanwhile, global deal volume was roughly flat, ticking up 1% QoQ to 851.

• CVCs participated in 33 $100M+ mega-rounds in Q1’24, tied for the highest total since Q3’22. The top 2 mega-rounds went to Wonder ($700M, with backing from American Express Ventures and Google Ventures) and Figure ($675M, with backing from Intel Capital, M12, NVentures, OpenAI Startup Fund, and Samsung Ventures).
• Early-stage companies have captured 66% of CVC deals in 2024 YTD, pacing at the highest share in over a decade. The increase is driven largely by Europe and Asia, which have seen 73% and 66% of deals this year go to early-stage companies, respectively. In the US, 59% of the year’s CVC deals are early-stage.
• CVC deals to fintech companies increased 41% QoQ to 165. This was the highest level since Q4’22. Blockchain investment firm OKX Ventures was the most active CVC across sectors, backing 27 total companies in Q1’24. Coinbase Ventures was also a top CVC last quarter with 11 companies backed, signaling a potential rebound in crypto-focused CVC activity. 
• CVC-backed funding in China fell to $0.3B, a 40% QoQ decrease. Deal volume also fell 14% QoQ to 78, its lowest level since Q1’20. Sungrow New Energy, a developer of renewable energy hardware, raised the largest round for China-based companies at $48M, with backing from CVC Zhongan Capital.

The post State of CVC Q1’24 Report appeared first on CB Insights Research.

Even so, median insurtech deal size is up in 2024 so far — signaling that investors are still willing to make notable bets where they see opportunities.

Here is the TL;DR on the state of insurtech:

• Insurtech funding falls 18% QoQ to hit $0.9B in Q1’24 — the lowest quarterly level since 2018. The decline was particularly pronounced in P&C insurtech, which saw funding drop by 25% QoQ. Meanwhile, broader insurtech deal count ticked up by 3% to reach 107 in Q1’24.

• No $100M+ mega-round insurtech deals are raised for the first time since 2018. Relatedly, late-stage deal share — which often comprises larger, mega-round deals — is down to 7% in 2024 so far. Hyperexponential, a pricing platform, raised the largest insurtech deal in Q1’24 — a $73M Series B round.
• Europe sees quarterly insurtech deal count rise for the first time since Q2’22. Europe-based insurtech startups raised 28 deals in Q1’24, up from 24 in Q4’23. Funding also more than tripled QoQ, rising to $284M in Q1’24. The region saw the 2 largest insurtech deals in Q1’24: Hyperexponential’s Series B round and embedded insurer ELEMENT’s $54M Series C round.
• Median insurtech deal size is $5M in 2024 so far, up 19% vs. $4.2M in full-year 2023. This elevated median deal size is partially linked to an uptick in median early-stage deal size, which sits at $3.2M in 2024 so far. Meanwhile, the average insurtech deal size in 2024 YTD ($9.8M) is down 17% from full-year 2023.
• Insurtech sees its fewest M&A exits since 2018. Exit activity has nearly halted in insurtech, with M&A exits declining from 13 in Q4’23 to just 5 in Q1’24. Comparatively, fintech M&A exits largely remained flat QoQ — ticking down from 153 in Q4’23 to 152 in Q1’24.

The post State of Insurtech Q1’24 Report appeared first on CB Insights Research.

Massive rounds to players like generative AI startup Anthropic were key drivers behind the jump, as overall AI deal volume dipped for the fourth straight quarter in Q1’24. 

Here is the TL;DR on the state of AI:

• Global AI funding reaches $13.1B. AI funding increased 24% QoQ to reach $13.1B — its highest quarterly level since Q1’23. This outpaced the growth in broader venture funding (+11%). Meanwhile, AI deals slipped for the fourth consecutive quarter, hitting their lowest quarterly count since 2018 (739 deals). This drop was particularly pronounced in Asia, which saw a 30% drop in deals QoQ.
  

• Average deal size YTD in AI is $23.1M, up 21% vs. $19.1M in full-year 2023. A couple of genAI infrastructure players have had an outsized impact on this upward trend, raising massive $1B+ deals: Anthropic ($2.8B Series D) and Moonshot AI ($1B Series B). Notably, Anthropic raised an additional deal worth $750M in Q1’24, bringing its total funding for the quarter to $3.5B.
• AI unicorn births remain steady at 6 QoQ in Q1’24. Three of these new unicorns are generative AI model developers: Moonshot AI, Together AI, and Krutrim all reached $1B+ valuations in Q1’24.
• AI M&A exits drop 36% in Q1’24. There were 69 M&A deals for AI companies in Q1’24, marking a 36% decrease from Q4’23. Amid the downturn, Europe saw its share of broader global exits rise by 12 percentage points QoQ, while Asia experienced a 15-point drop. Meanwhile, the US’ share remained steady at 41%.
• US AI funding rises 52% QoQ to reach $9.3B. Asia was the only other major global region to see a funding increase (+6%) in Q1’24. Funding totals for both regions were heavily buoyed by the $1B+ rounds to genAI infrastructure startups Anthropic (US) and Moonshot AI (China).

The post State of AI Q1’24 Report appeared first on CB Insights Research.

Digital health funding grew 48% quarter-over-quarter in Q1’24. This growth was supported by an increase in $100M+ mega-rounds, which were largely directed at biotech startups and other players leveraging AI.

Despite the increase, however, total funding still came in below pre-pandemic levels in Q1’24. Meanwhile, deal count continued to trend down.

Based on our deep dive below, here is the TL;DR on the state of digital health:

• ​Global digital health funding increases 48% QoQ to reach $3.7B in Q1’24. However, funding was still down 12% vs. Q1’23 and 63% vs. Q1’22. Meanwhile, digital health deal count declined in Q1’24, dropping to its lowest quarterly level since 2014.
  
  
• Funding to US digital health startups rises 44% QoQ. However, the US also saw deals drop to 144 — the fewest in a quarter since 2013. Despite the decline, the US still saw the majority of global digital health deals (53%) and funding (70%) in Q1’24. The US also secured 6 out of 7 digital health mega-rounds in the quarter.
• Average digital health deal size is up 38% in 2024 so far. After dropping from $23.1M in 2021 to $11.9M in 2023, average deal size is up to $16.4M in 2024 so far. This is being driven in part by the resurgence of mega-round deals. In Q1’24, these deals accounted for their second-highest share of quarterly funding since 2022.
• Digital health sees 7 $100M+ mega-rounds in Q1’24. Digital health mega-round deals rebounded QoQ in Q1’24. The largest digital health deal of the quarter went to Freenome — a biotech company focused on cancer detection. While biotech drove the top deals, Q1’24 mega-rounds were spread across the digital health industry, from biomedical NLP to robotics for microsurgery.
• No new unicorns (private companies valued at $1B+) emerge. While Freenome added $1B to its valuation following its Series F mega-round in February 2024, the company had already attained unicorn status in 2020. Among Q1’24 mega-round earners, Abridge saw the largest increase in disclosed valuation. It reached an $850M valuation — up 350% from October 2023.

The post State of Digital Health Q1’24 Report appeared first on CB Insights Research.

Fintech deal volume, on the other hand, increased for the first time since Q1’23.

Based on our deep dive below, here is the TL;DR on the state of fintech:

• Fintech funding falls 16% QoQ to its lowest quarterly level since 2017. Quarterly funding declined to $7.3B in Q1’24, counter to the 11% rebound in the broader venture market. That said, fintech deals increased by 15% QoQ as investors focus on writing smaller checks.
  
  
• Average deal size YTD in fintech is $11.1M, down 18% vs. $13.6M in full-year 2023. A dearth of blockbuster deals is driving the decline: In Q1’24, there were just 12 mega-rounds (deals worth $100M or more) representing 26% of total funding — the lowest share since Q2’23, when it hit 23%. Nevertheless, these rare deals can reach a massive scale: the biggest fintech round in the quarter was UK-based challenger bank Monzo‘s $431M Series I deal — worth 6% of the global funding total. 
• Mid- and late-stage deals make up 20% of deals YTD, up from 18% in full-year 2023, as investors look to startups with more established track records. So far this year, investors are favoring later-stage companies to a greater degree than the past 2 years. The shift is most pronounced within specific sectors. In payments, for instance, mid- and late-stage deals make up 29% of deals YTD, vs. 21% in 2023. In digital lending, mid- and late-stage deals make up 40% of deals YTD, nearly double the 2023 total.
• Banking startups have a billion-dollar quarter. Banking funding doubled in Q1’24 to reach $1B across 38 deals. Five of the top 10 banking deals in the quarter were late-stage, and 2 were mega-rounds of $100M+. Besides the Series I deal for Monzo, Germany-based banking-as-a-service company Solaris raised a $104M Series F round.
• Europe fintech funding increases 22% QoQ to $2.2B. Europe was the only major global region to see fintech funding increase in Q1’24. The continent also led all regions with 37% of exits in the quarter. Meanwhile, funding declined 11% QoQ to $3.3B in the US, which still led all regions in total fundraising.

The post State of Fintech Q1’24 Report appeared first on CB Insights Research.

Equity deal volume declined for an eighth straight quarter, but a handful of billion-dollar rounds — particularly in generative AI — helped drive funding up 11% quarter-over-quarter (QoQ).

Based on our deep dive below, here is the TL;DR on the state of venture:

• Venture funding climbs 11% QoQ to $58.4B. Q1 funding was buoyed by several massive deals, including Amazon’s $2.75B investment in generative AI company Anthropic. Despite the quarterly gain, funding remains down 21% vs. Q1’23 and 62% vs. Q1’22.
• Deals slide for an eighth straight quarter, down 7% to 6,238. Asia and Europe saw 8% and 9% declines, respectively, in VC deal activity. The US, on the other hand, bucked the global trend, seeing deals tick up 1% QoQ.
• Mega-rounds (deals worth $100M+) are a bright spot, growing 30% QoQ to 105. These large deals represented 45% of total funding in the quarter, up 11 percentage points from the previous quarter. Corporate investors like Amazon, Disney, and Alibaba were behind some of the largest deals. 
• The quarter sees 19 new unicorns spread across the US, Asia, and Europe, down slightly from 23 the previous quarter. Europe’s 5 new unicorns represented a 5-quarter high for the continent. The highest-valued unicorn birth in Q1’24 went to Figure, a humanoid robotics developer valued at $2.7B.
• The fintech sector takes a hit, with funding falling 16% QoQ, while digital health and retail tech see gains. Digital health funding surged by nearly 50% in Q1’24, driven by multiple biotech mega-rounds.
• Silicon Valley sees $4 out of every $10 in US funding. Silicon Valley startups drew $14.4B in Q1’24 — more than 3x the next US metro (New York with $4.4B) — to capture 42% of the country’s funding. While that figure was driven up in Q1’24 by Anthropic’s $3.5B in cumulative funding, it’s not an anomaly: Silicon Valley has seen over a third of all US funding since 2020.

Below, we’ll explore these themes across 8 charts.

Global venture funding grew 11% QoQ in Q1’24, bouncing back from a recent low to reach $58.4B. 

Despite the rebound, this figure marks a 21% decrease year-over-year and puts quarterly venture funding roughly where it was in 2017.

Meanwhile, dealmaking continued to slide in Q1’24. Equity deal volume slipped for an eighth straight quarter to 6,238, putting it in line with levels not seen since 2016/2017.

Globally, the US accounted for 39% of deals in the quarter — up 3 percentage points from Q4’23 — while Asia (31%) and Europe (24%) each lost 1 percentage point.

One of the bright spots in venture right now: mega-rounds (deals worth $100M+). These deals surged 30% QoQ (and 14% YoY) to hit 105 in Q1’24.

At $26.2B, funding from mega-rounds represented 45% of the quarter’s total funding — a rebound from 34% in Q4’23. 

The uptick in mega-rounds points to investors’ sustained interest in blockbuster deals, especially in capital-intensive areas like large language model development. 

Q1’24 saw 4 deals reach $1B or more in value, with 2 of these deals going to generative AI companies (Anthropic and Moonshot AI). Amazon and Alibaba led these respective deals, pointing to global tech giants’ rabid interest in genAI.

The other 2 deals worth $1B+ went to Epic Games and Generate Capital. Disney’s $1.5B stake in Epic is its biggest move into gaming yet, while Generate Capital’s $1.5B round will go toward developing sustainable infrastructure projects.

After falling precipitously throughout 2022, the number of new unicorns (private companies valued at $1B+) has mostly stabilized quarter-over-quarter. Q1’24 saw 19 new unicorns, down slightly from 23 the prior quarter.

The new billion-dollar companies in Q1 were distributed across the US (8 new unicorns), Asia (6), and Europe (5). 

Europe’s total, which represented a 5-quarter high in unicorn births for the continent, included new unicorns like Italy’s Bending Spoons ($2.6B valuation) and Netherlands-based Mews ($1.2B).

Some industries are seeing stronger funding momentum than others.

Digital health startups, for instance, saw funding soar 48% in Q1’24 to $3.7B. Top deals went to biotech firms Freenome ($254M Series F) and BioAge Labs ($170M Series D).

Fintech startups, on the other hand, drew 16% less funding in Q1’24 than the prior quarter. The fintech sector also saw its new unicorn count slip from 8 to 6 over the same period. Despite fintech’s funding losses, the sector was the only one to see an uptick in quarterly deal volume.

Silicon Valley remains the undisputed leader among US metros for VC activity. 

In Q1’24, Silicon Valley-based startups drew $14.4B in funding — 42% of the US total. This represented a 14-point surge QoQ in Silicon Valley’s share of funding, driven in large part by the excitement around AI. San Francisco-based Anthropic, an OpenAI competitor, was responsible for 10% of total US funding in the quarter.

Here are the funding totals for the top 5 US metros in Q1’24:

1. Silicon Valley: $14.4B
2. New York: $4.4B
3. Los Angeles: $2.5B
4. Boston: $2B
5. Raleigh: $1.6B (driven by Epic Games’ $1.5B round)

On a global scale, funding climbed 33% QoQ in the US — more than Europe’s 8% increase over the same period. Asia, meanwhile, watched its funding total fall 20% to $10.2B, putting it in the #3 spot behind second-ranked Europe.

The US accounted for 59% of total funding this past quarter — an increase of 10 percentage points from Q4’23. The top 3 largest deals in Q1’24 all went to US-based firms.

The post State of Venture Q1’24 Report appeared first on CB Insights Research.

At the same time, fewer new CVCs are emerging: just 162 CVCs were founded in 2023 — a 6-year low.

Based on our deep dive below, here is the TLDR on the state of corporate venture:

• CVC activity is down significantly from 2021’s highs, with CVC-backed dollars and deals sinking to $55.1B across 3,545 deals in 2023. The decline in funding with CVC participation has been especially pronounced, while dealmaking, despite falling 32% YoY, remains above where it was in 2019. 
• The US has been hit especially hard by the CVC retreat: Deal volume fell 25% QoQ to 233, a 6-year low, in Q4’23. This drove the US’ share of CVC deals down to just 29% among global regions — the lowest point in over a decade.
• A majority of the most active CVCs are based in Japan. The top 3 dealmakers in Q4’23 were all venture arms of Japanese financial services incumbents: Mitsubishi UFJ Capital (22 companies backed), SMBC Venture Capital (18), and Mizuho Capital (15).
• A generative AI company took the top CVC-backed deal in Q4’23. Aleph Alpha, a Germany-based LLM developer, raised a $500M round from investors including the venture arms of Bosch and Hubert Burda Media.
• Early-stage deal share has remained at an all-time high of 63% for 2 years running. CVCs are showing sustained interest in the earliest stages of startups, where they can form deep, long-term partnerships (and hopefully see greater financial returns in the long run).

Below, we’ll explore these themes across 5 charts.

CB Insights customers can dig into the latest corporate venture activity with this CB Insights platform advanced search.

2023 marked a precipitous drop in CVC activity globally, with funding and deals falling 46% and 32% YoY, respectively. This was roughly in line with the declines seen throughout the venture market more broadly.

Facing macroeconomic uncertainty, many CVCs are narrowing their bets on investment targets that align more closely with their parent orgs’ overarching strategies, as opposed to purely seeking financial returns.

The CVC pullback has been dramatic in the US, where deal volume slumped to just 233 in Q4’23 — a QoQ drop of 25%. 

Meanwhile, Asia and Europe saw growth in CVC activity in Q4’23, signaling the potential for a rebound in 2024.

The US’ share of global CVC-backed deals slipped below 30% for the first time in over a decade — while Asia’s share ticked up to a recent high of 42%. 

Globally, Japan stands out as the capital of CVC activity right now. The majority of the most active CVCs are based in the country, including the top 3 dealmakers in Q4’23: Mitsubishi UFJ Capital (22 companies backed), SMBC Venture Capital (18), and Mizuho Capital (15).

Across the broader venture market, Japan’s startups have been on a tear, notching consistently high deal counts each quarter despite the global downturn.

The generative AI boom has captured CVCs’ attention.

Germany-based Aleph Alpha, an LLM developer, took the top CVC-backed round of Q4’23 — with participation from the venture arms of Germany’s Bosch and Hubert Burda Media.

CB Insights customers can track every generative AI deal with corporate venture backing here.

One of the few bright spots in CVC right now is early-stage dealmaking. In 2023, 63% of all CVC deals were early-stage — maintaining the all-time high from 2022. 

CVCs are moving earlier in the startup lifecycle as they look to establish closer ties with emerging startups.

The post State of CVC 2023 Report appeared first on CB Insights Research.